Multimodal neuroimaging of cue-induced craving and cortical alterations in etomidate use disorder

Despite the escalating global abuse of etomidate, a GABA A -specific anesthetic, the neurobiological mechanisms underlying craving and structural brain alterations remain poorly understood. This case-control study aimed to identify the neural characteristics of cue-induced craving and cortical brain changes in etomidate use disorder (EUD). Right-hand males aged 18–45 years meeting DSM-5 criteria for EUD and age-matched healthy males for controls (HC) were recruited in Guangzhou, China, between June 2023 and October 2024. Within a cue-reactivity paradigm, spatiotemporal neural dynamics of drug craving were investigated using multimodal neuroimaging, including electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) in independent cohorts. Effective connectivity was analyzed with dynamic causal modeling (DCM), and structural MRI (sMRI) was further employed to assess cortical thickness. EEG analyses demonstrated amplified frontocentral late positive potential (LPP) amplitudes in response to drug cues in the EUD group, which correlated with subjective craving. FMRI analyses revealed cue-induced hyperactivation in the temporoparietal junction (TPJ) and ventrolateral prefrontal cortex (VLPFC). Signed cue-modulated DCM parameters indicated abnormal VLPFC-to-TPJ inhibitory modulation in the EUD group, with weaker inhibitory modulation associated with higher subjective craving. Furthermore, sMRI identified widespread cortical thinning across prefrontal, parietal, occipitotemporal, and limbic regions among EUD individuals. These findings suggest that chronic etomidate exposure is associated with altered VLPFC function, maladaptive top-down inhibition within the VLPFC-TPJ connectivity, and heightened salience attribution to drug cues. These findings highlight the VLPFC-TPJ circuit as a promising neuromodulation target for treating EUD, underscoring its clinical potential in addressing this growing public health issue.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-10-14
DOI
https://doi.org/10.1186/s12916-026-05253-5
Primary Topic
Substance Abuse Treatment and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodal neuroimaging of cue-induced craving and cortical alterations in etomidate use disorder

Shenghong Zhao, 鲍彦平, Tianye Jia, Lin Lü et al.
BMC Medicine
Substance Abuse Treatment and Outcomes
article

Multimodal neuroimaging of cue-induced craving and cortical alterations in etomidate use disorder

Shenghong Zhao, 鲍彦平, Tianye Jia, Lin Lü, Yuchen Huang, Wangyue Liu, Mingming Zhang, Sizhi Ai, Junwei Zheng, Taoyu Wu, Jie Shi, Jingli Yue, Yan Sun
article en

Abstract

Despite the escalating global abuse of etomidate, a GABA A -specific anesthetic, the neurobiological mechanisms underlying craving and structural brain alterations remain poorly understood. This case-control study aimed to identify the neural characteristics of cue-induced craving and cortical brain changes in etomidate use disorder (EUD). Right-hand males aged 18–45 years meeting DSM-5 criteria for EUD and age-matched healthy males for controls (HC) were recruited in Guangzhou, China, between June 2023 and October 2024. Within a cue-reactivity paradigm, spatiotemporal neural dynamics of drug craving were investigated using multimodal neuroimaging, including electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) in independent cohorts. Effective connectivity was analyzed with dynamic causal modeling (DCM), and structural MRI (sMRI) was further employed to assess cortical thickness. EEG analyses demonstrated amplified frontocentral late positive potential (LPP) amplitudes in response to drug cues in the EUD group, which correlated with subjective craving. FMRI analyses revealed cue-induced hyperactivation in the temporoparietal junction (TPJ) and ventrolateral prefrontal cortex (VLPFC). Signed cue-modulated DCM parameters indicated abnormal VLPFC-to-TPJ inhibitory modulation in the EUD group, with weaker inhibitory modulation associated with higher subjective craving. Furthermore, sMRI identified widespread cortical thinning across prefrontal, parietal, occipitotemporal, and limbic regions among EUD individuals. These findings suggest that chronic etomidate exposure is associated with altered VLPFC function, maladaptive top-down inhibition within the VLPFC-TPJ connectivity, and heightened salience attribution to drug cues. These findings highlight the VLPFC-TPJ circuit as a promising neuromodulation target for treating EUD, underscoring its clinical potential in addressing this growing public health issue.

BMC Medicine
Liaoning Normal University (CN), Peking University (CN), Peking University Sixth Hospital (CN), Shandong First Medical University (CN), Guangzhou Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 13%
Substance Abuse Treatment and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.